GSK VS CI Stock Comparison
Performance
GSK10/100
10/100
GSK returned 3.98% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
CI10/100
10/100
CI returned -5.25% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
GSK63/100
63/100
4 analysts offer 12-month price targets for GSK. Together, they have an average target of 0, the most optimistic target put GSK at 0 within 12-months and the most pessimistic has GSK at 0.
CI78/100
78/100
17 analysts offer 12-month price targets for CI. Together, they have an average target of 284.65, the most optimistic target put CI at 370 within 12-months and the most pessimistic has CI at 225.
Technicals
GSK10/100
10/100
GSK receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.
CI32/100
32/100
CI receives a 32 of 100 based on 14 indicators. 4 are bullish, 9 are bearish.
Earnings
GSK66/100
66/100
GSK has missed earnings 3 times in the last 20 quarters.
CI100/100
100/100
CI has missed earnings 1 times in the last 20 quarters.
Profit
GSK72/100
72/100
Out of the last 20 quarters, GSK has had 20 profitable quarters and has increased their profits year over year on 7 of them.
CI71/100
71/100
Out of the last 20 quarters, CI has had 20 profitable quarters and has increased their profits year over year on 9 of them.
Volatility
GSK56/100
56/100
GSK has had a higher than average amount of volatility over the last 12 months giving it a score of 56 of 100.
CI48/100
48/100
CI has had a lower than average amount of volatility over the last 12 months giving it a score of 48 of 100.
All score calculations are broken down here to help you make more informed investing decisions
GSK plc American Depositary Shares (Each representing two Ordinary Shares) Summary
New York Stock Exchange / GSK
Healthcare
Drug Manufacturers - General
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
The Cigna Group Summary
New York Stock Exchange / CI
Healthcare
Medical - Healthcare Plans
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare GSK to other companies in the same or a similar industry.